methylprednisolone has been researched along with Androgen-Independent Prostatic Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosch, B; Chapas-Reed, J; Dreicer, R; Given, R; Higano, CS; Levin, R; Nemeth, P; Stein, CA | 1 |
| Hongo, H; Kosaka, T; Oya, M; Yanai, Y | 1 |
1 trial(s) available for methylprednisolone and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study.
Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Gastrointestinal Diseases; Humans; Male; Methylprednisolone; Middle Aged; Neoplasm Metastasis; Particle Size; Prednisone; Prostatic Neoplasms, Castration-Resistant; Therapeutic Equivalency | 2018 |
1 other study(ies) available for methylprednisolone and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Interstitial pneumonitis in a castration-resistant prostate cancer patient receiving cabazitaxel after thoracic radiation therapy: a case report.
Topics: Administration, Intravenous; Aged; Antineoplastic Agents; Docetaxel; Drug Resistance, Neoplasm; Dyspnea; Follow-Up Studies; Glucocorticoids; Humans; Lung Diseases, Interstitial; Male; Methylprednisolone; Prostatic Neoplasms, Castration-Resistant; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2019 |